ASHLEY LAVALLEY: Open Payments
NPI 1720698319 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$974 in 50 payments from 13 companies in 2025. Trend: 2023 $142 · 2024 $454 · 2025 $974
Food & beverage: $890Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $278 |
| ABBVIE INC. | 13 | $170 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110 |
| Ipsen Biopharmaceuticals, Inc | 4 | $90 |
| Ardelyx, Inc. | 3 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $71 |
| Novo Nordisk Inc | 2 | $36 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Intercept Pharmaceuticals, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
Products named: TREMFYA, LINZESS, IQIRVO, IBSRELA, ENTYVIO, XIFAXAN, EOHILIA, Wegovy.
Industry payments across NY — which companies pay providers there.
